Hemerion has been developing cancer-fighting therapies from 2010 on. Our team is supported by a consistent network of scientific, clinical and financial partners.
Clinical development
Mount Sinai Health System
Mount Sinai Health System encompasses the Icahn School of Medicine and eight hospital campuses in the New York metropolitan area. Mount Sinai Health System will host several clinical trials of the Hemerion technology.
Centre Hospitalo-Universitaire de Lille
As the regional referral centre and major teaching hospital, Lille University Hospital provides the highest quality care to the North of France. Lille University Hospital has sponsored the first clinical trial evaluating the Hemerion technology.
Research & Development
INSERM / OncoThai / Lille University
Hemerion develops technologies that originate from the research in Photodynamic Therapies led by the Onco ThAI team, a joint research group gathering Inserm, the University of Lille and the Lille University Hospital.
SATT Nord
SATT manages the technology transfer from french publicly funded research toward industry.
Strategic support
Eurasanté
Eurasanté is a development agency dedicated to tech transfer and business development in the life sciences sector.
Neighborhood
Neighborhood is a life science innovation center that offers tailored mentoring, coaching and global access to health tech entrepreneurs.
Financing
Hemerion is funded by a wide network of public and private investors.
